Cart (0 Items)
Your cart is currently empty.
View ProductsWhy choose us for your veterinary antibody project?
Why does veterinary antibody development have to be so costly and slow?
Veterinary antibody development comes with a unique set of challenges. From the limited availability of species-specific libraries and reagents, to the sheer biological diversity across target animals — all compounded by the pressure to deliver within tight timelines and budgets.
It doesn’t have to be this way. Whether you’re working with a tight timeline, a limited budget, or a hard-to-target animal species, ProteoGenix has the expertise and technology to move your project forward. From early-stage discovery to final delivery, we offer tailored solutions that adapt to your constraints; not the other way around.
|
|
Are you developing a veterinary antibody?
Explore our services or contact us for advise
Finding the right resource or technology for your target animal shouldn’t be this hard
Most antibody service providers cover only a few species, leaving veterinary researchers to compromise on their model or start from scratch. ProteoGenix removes that barrier with one of the widest species-specific phage display library collections on the market — including companion animals such as cats, dogs and rabbits, as well as major livestock species like horses, pigs and cows.
Our ScFv & Fab Pet libraries
0
Breeds of dogs
0
Breeds of cats
0
Breeds of rabbits
0¹⁰
Clones per library on average
-
Custom dog monoclonal antibodies
- Beagle
- German Shepherd
- Labrador
- English Coonhound
- Great Dane
- Chinese Rural Dog
-
Custom cat monoclonal antibodies
- Ragdoll
- Maine Coon
- Persian
- Domestic Shorthair
- Domestic Longhair
- American Shorthair
- Siamese
- Bengal
Our ScFv & Fab Cattle libraries
-
Horse Antibodies
-
Cow Antibodies
Guidance and experience on animal health through your entire therapeutic journey
Bringing a veterinary therapeutic to market is a long and complex road. ProteoGenix brings deep animal health expertise to every stage of your project.
With years of experience in veterinary antibody development, our experts have guided countless research and therapeutic programs toward the right strategy — saving time, reducing costs, and avoiding dead ends. Whether you’re weighing hybridoma technology, phage display, or AI-based methods, we help you make an informed decision from day one. To get started, explore our practical decision guide.
Bringing your project to life with Proteogenix
ProteoGenix’s Dog Phage Display Library
Mazouari, K. E. & Abnomx BV. (2022). WO2023161448A1 – Human-like Target-binding proteins – Google Patents (Patent No WO2023161448A1). https://patents.google.com/patent/WO2023161448A1/
Do you need guidance for your veterinary antibody development?
Learn more about our services or contact our experts
